Global Psychedelic Medicine Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Psychedelic Medicine market size was valued at US$ million in 2023. With growing demand in downstream market, the Psychedelic Medicine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Psychedelic Medicine market. Psychedelic Medicine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Psychedelic Medicine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Psychedelic Medicine market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Psychedelic Medicine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Psychedelic Medicine market. It may include historical data, market segmentation by Type (e.g., Psilocybin, LSD), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Psychedelic Medicine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Psychedelic Medicine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Psychedelic Medicine industry. This include advancements in Psychedelic Medicine technology, Psychedelic Medicine new entrants, Psychedelic Medicine new investment, and other innovations that are shaping the future of Psychedelic Medicine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Psychedelic Medicine market. It includes factors influencing customer ' purchasing decisions, preferences for Psychedelic Medicine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Psychedelic Medicine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Psychedelic Medicine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Psychedelic Medicine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Psychedelic Medicine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Psychedelic Medicine market.
Market Segmentation:
Psychedelic Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Psychedelic Medicine market size was valued at US$ million in 2023. With growing demand in downstream market, the Psychedelic Medicine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Psychedelic Medicine market. Psychedelic Medicine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Psychedelic Medicine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Psychedelic Medicine market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Psychedelic Medicine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Psychedelic Medicine market. It may include historical data, market segmentation by Type (e.g., Psilocybin, LSD), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Psychedelic Medicine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Psychedelic Medicine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Psychedelic Medicine industry. This include advancements in Psychedelic Medicine technology, Psychedelic Medicine new entrants, Psychedelic Medicine new investment, and other innovations that are shaping the future of Psychedelic Medicine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Psychedelic Medicine market. It includes factors influencing customer ' purchasing decisions, preferences for Psychedelic Medicine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Psychedelic Medicine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Psychedelic Medicine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Psychedelic Medicine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Psychedelic Medicine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Psychedelic Medicine market.
Market Segmentation:
Psychedelic Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Others
- Depressive Disorders
- Post-Traumatic Stress Disorders
- Substance Abuse Disorders
- Obsessive Compulsive Disorders
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- COMPASS Pathways PLC
- Pfizer
- Eli Lilly
- GlaxoSmithKline
- Cybin Inc
- Field Trip Health
- ATAI Life Sciences
- NUMINUS WELLNESS
- MindMed
- HAVN Life Sciences
- Seelos Therapeutics
- Jannsen
- Acadia Pharmaceuticals
- Intellipharmaceutics
- Revive Therapeutics
- Mydecine Innovations Group
- Red Light Holland
- Braxia Scientific
- Mind Cure Health
- Entheon Biomedical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psychedelic Medicine Market Size 2019-2030
2.1.2 Psychedelic Medicine Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Psychedelic Medicine Segment by Type
2.2.1 Psilocybin
2.2.2 LSD
2.2.3 MDMA
2.2.4 DMT
2.2.5 Ketamine
2.2.6 Others
2.3 Psychedelic Medicine Market Size by Type
2.3.1 Psychedelic Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Psychedelic Medicine Market Size Market Share by Type (2019-2024)
2.4 Psychedelic Medicine Segment by Application
2.4.1 Depressive Disorders
2.4.2 Post-Traumatic Stress Disorders
2.4.3 Substance Abuse Disorders
2.4.4 Obsessive Compulsive Disorders
2.4.5 Others
2.5 Psychedelic Medicine Market Size by Application
2.5.1 Psychedelic Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Psychedelic Medicine Market Size Market Share by Application (2019-2024)
3 PSYCHEDELIC MEDICINE MARKET SIZE BY PLAYER
3.1 Psychedelic Medicine Market Size Market Share by Players
3.1.1 Global Psychedelic Medicine Revenue by Players (2019-2024)
3.1.2 Global Psychedelic Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Psychedelic Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSYCHEDELIC MEDICINE BY REGIONS
4.1 Psychedelic Medicine Market Size by Regions (2019-2024)
4.2 Americas Psychedelic Medicine Market Size Growth (2019-2024)
4.3 APAC Psychedelic Medicine Market Size Growth (2019-2024)
4.4 Europe Psychedelic Medicine Market Size Growth (2019-2024)
4.5 Middle East & Africa Psychedelic Medicine Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Psychedelic Medicine Market Size by Country (2019-2024)
5.2 Americas Psychedelic Medicine Market Size by Type (2019-2024)
5.3 Americas Psychedelic Medicine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psychedelic Medicine Market Size by Region (2019-2024)
6.2 APAC Psychedelic Medicine Market Size by Type (2019-2024)
6.3 APAC Psychedelic Medicine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psychedelic Medicine by Country (2019-2024)
7.2 Europe Psychedelic Medicine Market Size by Type (2019-2024)
7.3 Europe Psychedelic Medicine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psychedelic Medicine by Region (2019-2024)
8.2 Middle East & Africa Psychedelic Medicine Market Size by Type (2019-2024)
8.3 Middle East & Africa Psychedelic Medicine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSYCHEDELIC MEDICINE MARKET FORECAST
10.1 Global Psychedelic Medicine Forecast by Regions (2025-2030)
10.1.1 Global Psychedelic Medicine Forecast by Regions (2025-2030)
10.1.2 Americas Psychedelic Medicine Forecast
10.1.3 APAC Psychedelic Medicine Forecast
10.1.4 Europe Psychedelic Medicine Forecast
10.1.5 Middle East & Africa Psychedelic Medicine Forecast
10.2 Americas Psychedelic Medicine Forecast by Country (2025-2030)
10.2.1 United States Psychedelic Medicine Market Forecast
10.2.2 Canada Psychedelic Medicine Market Forecast
10.2.3 Mexico Psychedelic Medicine Market Forecast
10.2.4 Brazil Psychedelic Medicine Market Forecast
10.3 APAC Psychedelic Medicine Forecast by Region (2025-2030)
10.3.1 China Psychedelic Medicine Market Forecast
10.3.2 Japan Psychedelic Medicine Market Forecast
10.3.3 Korea Psychedelic Medicine Market Forecast
10.3.4 Southeast Asia Psychedelic Medicine Market Forecast
10.3.5 India Psychedelic Medicine Market Forecast
10.3.6 Australia Psychedelic Medicine Market Forecast
10.4 Europe Psychedelic Medicine Forecast by Country (2025-2030)
10.4.1 Germany Psychedelic Medicine Market Forecast
10.4.2 France Psychedelic Medicine Market Forecast
10.4.3 UK Psychedelic Medicine Market Forecast
10.4.4 Italy Psychedelic Medicine Market Forecast
10.4.5 Russia Psychedelic Medicine Market Forecast
10.5 Middle East & Africa Psychedelic Medicine Forecast by Region (2025-2030)
10.5.1 Egypt Psychedelic Medicine Market Forecast
10.5.2 South Africa Psychedelic Medicine Market Forecast
10.5.3 Israel Psychedelic Medicine Market Forecast
10.5.4 Turkey Psychedelic Medicine Market Forecast
10.5.5 GCC Countries Psychedelic Medicine Market Forecast
10.6 Global Psychedelic Medicine Forecast by Type (2025-2030)
10.7 Global Psychedelic Medicine Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 COMPASS Pathways PLC
11.1.1 COMPASS Pathways PLC Company Information
11.1.2 COMPASS Pathways PLC Psychedelic Medicine Product Offered
11.1.3 COMPASS Pathways PLC Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 COMPASS Pathways PLC Main Business Overview
11.1.5 COMPASS Pathways PLC Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Psychedelic Medicine Product Offered
11.2.3 Pfizer Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Psychedelic Medicine Product Offered
11.3.3 Eli Lilly Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Psychedelic Medicine Product Offered
11.4.3 GlaxoSmithKline Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 Cybin Inc
11.5.1 Cybin Inc Company Information
11.5.2 Cybin Inc Psychedelic Medicine Product Offered
11.5.3 Cybin Inc Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cybin Inc Main Business Overview
11.5.5 Cybin Inc Latest Developments
11.6 Field Trip Health
11.6.1 Field Trip Health Company Information
11.6.2 Field Trip Health Psychedelic Medicine Product Offered
11.6.3 Field Trip Health Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Field Trip Health Main Business Overview
11.6.5 Field Trip Health Latest Developments
11.7 ATAI Life Sciences
11.7.1 ATAI Life Sciences Company Information
11.7.2 ATAI Life Sciences Psychedelic Medicine Product Offered
11.7.3 ATAI Life Sciences Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 ATAI Life Sciences Main Business Overview
11.7.5 ATAI Life Sciences Latest Developments
11.8 NUMINUS WELLNESS
11.8.1 NUMINUS WELLNESS Company Information
11.8.2 NUMINUS WELLNESS Psychedelic Medicine Product Offered
11.8.3 NUMINUS WELLNESS Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 NUMINUS WELLNESS Main Business Overview
11.8.5 NUMINUS WELLNESS Latest Developments
11.9 MindMed
11.9.1 MindMed Company Information
11.9.2 MindMed Psychedelic Medicine Product Offered
11.9.3 MindMed Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 MindMed Main Business Overview
11.9.5 MindMed Latest Developments
11.10 HAVN Life Sciences
11.10.1 HAVN Life Sciences Company Information
11.10.2 HAVN Life Sciences Psychedelic Medicine Product Offered
11.10.3 HAVN Life Sciences Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 HAVN Life Sciences Main Business Overview
11.10.5 HAVN Life Sciences Latest Developments
11.11 Seelos Therapeutics
11.11.1 Seelos Therapeutics Company Information
11.11.2 Seelos Therapeutics Psychedelic Medicine Product Offered
11.11.3 Seelos Therapeutics Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Seelos Therapeutics Main Business Overview
11.11.5 Seelos Therapeutics Latest Developments
11.12 Jannsen
11.12.1 Jannsen Company Information
11.12.2 Jannsen Psychedelic Medicine Product Offered
11.12.3 Jannsen Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Jannsen Main Business Overview
11.12.5 Jannsen Latest Developments
11.13 Acadia Pharmaceuticals
11.13.1 Acadia Pharmaceuticals Company Information
11.13.2 Acadia Pharmaceuticals Psychedelic Medicine Product Offered
11.13.3 Acadia Pharmaceuticals Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Acadia Pharmaceuticals Main Business Overview
11.13.5 Acadia Pharmaceuticals Latest Developments
11.14 Intellipharmaceutics
11.14.1 Intellipharmaceutics Company Information
11.14.2 Intellipharmaceutics Psychedelic Medicine Product Offered
11.14.3 Intellipharmaceutics Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Intellipharmaceutics Main Business Overview
11.14.5 Intellipharmaceutics Latest Developments
11.15 Revive Therapeutics
11.15.1 Revive Therapeutics Company Information
11.15.2 Revive Therapeutics Psychedelic Medicine Product Offered
11.15.3 Revive Therapeutics Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Revive Therapeutics Main Business Overview
11.15.5 Revive Therapeutics Latest Developments
11.16 Mydecine Innovations Group
11.16.1 Mydecine Innovations Group Company Information
11.16.2 Mydecine Innovations Group Psychedelic Medicine Product Offered
11.16.3 Mydecine Innovations Group Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Mydecine Innovations Group Main Business Overview
11.16.5 Mydecine Innovations Group Latest Developments
11.17 Red Light Holland
11.17.1 Red Light Holland Company Information
11.17.2 Red Light Holland Psychedelic Medicine Product Offered
11.17.3 Red Light Holland Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Red Light Holland Main Business Overview
11.17.5 Red Light Holland Latest Developments
11.18 Braxia Scientific
11.18.1 Braxia Scientific Company Information
11.18.2 Braxia Scientific Psychedelic Medicine Product Offered
11.18.3 Braxia Scientific Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Braxia Scientific Main Business Overview
11.18.5 Braxia Scientific Latest Developments
11.19 Mind Cure Health
11.19.1 Mind Cure Health Company Information
11.19.2 Mind Cure Health Psychedelic Medicine Product Offered
11.19.3 Mind Cure Health Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Mind Cure Health Main Business Overview
11.19.5 Mind Cure Health Latest Developments
11.20 Entheon Biomedical
11.20.1 Entheon Biomedical Company Information
11.20.2 Entheon Biomedical Psychedelic Medicine Product Offered
11.20.3 Entheon Biomedical Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Entheon Biomedical Main Business Overview
11.20.5 Entheon Biomedical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psychedelic Medicine Market Size 2019-2030
2.1.2 Psychedelic Medicine Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Psychedelic Medicine Segment by Type
2.2.1 Psilocybin
2.2.2 LSD
2.2.3 MDMA
2.2.4 DMT
2.2.5 Ketamine
2.2.6 Others
2.3 Psychedelic Medicine Market Size by Type
2.3.1 Psychedelic Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Psychedelic Medicine Market Size Market Share by Type (2019-2024)
2.4 Psychedelic Medicine Segment by Application
2.4.1 Depressive Disorders
2.4.2 Post-Traumatic Stress Disorders
2.4.3 Substance Abuse Disorders
2.4.4 Obsessive Compulsive Disorders
2.4.5 Others
2.5 Psychedelic Medicine Market Size by Application
2.5.1 Psychedelic Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Psychedelic Medicine Market Size Market Share by Application (2019-2024)
3 PSYCHEDELIC MEDICINE MARKET SIZE BY PLAYER
3.1 Psychedelic Medicine Market Size Market Share by Players
3.1.1 Global Psychedelic Medicine Revenue by Players (2019-2024)
3.1.2 Global Psychedelic Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Psychedelic Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSYCHEDELIC MEDICINE BY REGIONS
4.1 Psychedelic Medicine Market Size by Regions (2019-2024)
4.2 Americas Psychedelic Medicine Market Size Growth (2019-2024)
4.3 APAC Psychedelic Medicine Market Size Growth (2019-2024)
4.4 Europe Psychedelic Medicine Market Size Growth (2019-2024)
4.5 Middle East & Africa Psychedelic Medicine Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Psychedelic Medicine Market Size by Country (2019-2024)
5.2 Americas Psychedelic Medicine Market Size by Type (2019-2024)
5.3 Americas Psychedelic Medicine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psychedelic Medicine Market Size by Region (2019-2024)
6.2 APAC Psychedelic Medicine Market Size by Type (2019-2024)
6.3 APAC Psychedelic Medicine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psychedelic Medicine by Country (2019-2024)
7.2 Europe Psychedelic Medicine Market Size by Type (2019-2024)
7.3 Europe Psychedelic Medicine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psychedelic Medicine by Region (2019-2024)
8.2 Middle East & Africa Psychedelic Medicine Market Size by Type (2019-2024)
8.3 Middle East & Africa Psychedelic Medicine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSYCHEDELIC MEDICINE MARKET FORECAST
10.1 Global Psychedelic Medicine Forecast by Regions (2025-2030)
10.1.1 Global Psychedelic Medicine Forecast by Regions (2025-2030)
10.1.2 Americas Psychedelic Medicine Forecast
10.1.3 APAC Psychedelic Medicine Forecast
10.1.4 Europe Psychedelic Medicine Forecast
10.1.5 Middle East & Africa Psychedelic Medicine Forecast
10.2 Americas Psychedelic Medicine Forecast by Country (2025-2030)
10.2.1 United States Psychedelic Medicine Market Forecast
10.2.2 Canada Psychedelic Medicine Market Forecast
10.2.3 Mexico Psychedelic Medicine Market Forecast
10.2.4 Brazil Psychedelic Medicine Market Forecast
10.3 APAC Psychedelic Medicine Forecast by Region (2025-2030)
10.3.1 China Psychedelic Medicine Market Forecast
10.3.2 Japan Psychedelic Medicine Market Forecast
10.3.3 Korea Psychedelic Medicine Market Forecast
10.3.4 Southeast Asia Psychedelic Medicine Market Forecast
10.3.5 India Psychedelic Medicine Market Forecast
10.3.6 Australia Psychedelic Medicine Market Forecast
10.4 Europe Psychedelic Medicine Forecast by Country (2025-2030)
10.4.1 Germany Psychedelic Medicine Market Forecast
10.4.2 France Psychedelic Medicine Market Forecast
10.4.3 UK Psychedelic Medicine Market Forecast
10.4.4 Italy Psychedelic Medicine Market Forecast
10.4.5 Russia Psychedelic Medicine Market Forecast
10.5 Middle East & Africa Psychedelic Medicine Forecast by Region (2025-2030)
10.5.1 Egypt Psychedelic Medicine Market Forecast
10.5.2 South Africa Psychedelic Medicine Market Forecast
10.5.3 Israel Psychedelic Medicine Market Forecast
10.5.4 Turkey Psychedelic Medicine Market Forecast
10.5.5 GCC Countries Psychedelic Medicine Market Forecast
10.6 Global Psychedelic Medicine Forecast by Type (2025-2030)
10.7 Global Psychedelic Medicine Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 COMPASS Pathways PLC
11.1.1 COMPASS Pathways PLC Company Information
11.1.2 COMPASS Pathways PLC Psychedelic Medicine Product Offered
11.1.3 COMPASS Pathways PLC Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 COMPASS Pathways PLC Main Business Overview
11.1.5 COMPASS Pathways PLC Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Psychedelic Medicine Product Offered
11.2.3 Pfizer Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Psychedelic Medicine Product Offered
11.3.3 Eli Lilly Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Psychedelic Medicine Product Offered
11.4.3 GlaxoSmithKline Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 Cybin Inc
11.5.1 Cybin Inc Company Information
11.5.2 Cybin Inc Psychedelic Medicine Product Offered
11.5.3 Cybin Inc Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cybin Inc Main Business Overview
11.5.5 Cybin Inc Latest Developments
11.6 Field Trip Health
11.6.1 Field Trip Health Company Information
11.6.2 Field Trip Health Psychedelic Medicine Product Offered
11.6.3 Field Trip Health Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Field Trip Health Main Business Overview
11.6.5 Field Trip Health Latest Developments
11.7 ATAI Life Sciences
11.7.1 ATAI Life Sciences Company Information
11.7.2 ATAI Life Sciences Psychedelic Medicine Product Offered
11.7.3 ATAI Life Sciences Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 ATAI Life Sciences Main Business Overview
11.7.5 ATAI Life Sciences Latest Developments
11.8 NUMINUS WELLNESS
11.8.1 NUMINUS WELLNESS Company Information
11.8.2 NUMINUS WELLNESS Psychedelic Medicine Product Offered
11.8.3 NUMINUS WELLNESS Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 NUMINUS WELLNESS Main Business Overview
11.8.5 NUMINUS WELLNESS Latest Developments
11.9 MindMed
11.9.1 MindMed Company Information
11.9.2 MindMed Psychedelic Medicine Product Offered
11.9.3 MindMed Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 MindMed Main Business Overview
11.9.5 MindMed Latest Developments
11.10 HAVN Life Sciences
11.10.1 HAVN Life Sciences Company Information
11.10.2 HAVN Life Sciences Psychedelic Medicine Product Offered
11.10.3 HAVN Life Sciences Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 HAVN Life Sciences Main Business Overview
11.10.5 HAVN Life Sciences Latest Developments
11.11 Seelos Therapeutics
11.11.1 Seelos Therapeutics Company Information
11.11.2 Seelos Therapeutics Psychedelic Medicine Product Offered
11.11.3 Seelos Therapeutics Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Seelos Therapeutics Main Business Overview
11.11.5 Seelos Therapeutics Latest Developments
11.12 Jannsen
11.12.1 Jannsen Company Information
11.12.2 Jannsen Psychedelic Medicine Product Offered
11.12.3 Jannsen Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Jannsen Main Business Overview
11.12.5 Jannsen Latest Developments
11.13 Acadia Pharmaceuticals
11.13.1 Acadia Pharmaceuticals Company Information
11.13.2 Acadia Pharmaceuticals Psychedelic Medicine Product Offered
11.13.3 Acadia Pharmaceuticals Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Acadia Pharmaceuticals Main Business Overview
11.13.5 Acadia Pharmaceuticals Latest Developments
11.14 Intellipharmaceutics
11.14.1 Intellipharmaceutics Company Information
11.14.2 Intellipharmaceutics Psychedelic Medicine Product Offered
11.14.3 Intellipharmaceutics Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Intellipharmaceutics Main Business Overview
11.14.5 Intellipharmaceutics Latest Developments
11.15 Revive Therapeutics
11.15.1 Revive Therapeutics Company Information
11.15.2 Revive Therapeutics Psychedelic Medicine Product Offered
11.15.3 Revive Therapeutics Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Revive Therapeutics Main Business Overview
11.15.5 Revive Therapeutics Latest Developments
11.16 Mydecine Innovations Group
11.16.1 Mydecine Innovations Group Company Information
11.16.2 Mydecine Innovations Group Psychedelic Medicine Product Offered
11.16.3 Mydecine Innovations Group Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Mydecine Innovations Group Main Business Overview
11.16.5 Mydecine Innovations Group Latest Developments
11.17 Red Light Holland
11.17.1 Red Light Holland Company Information
11.17.2 Red Light Holland Psychedelic Medicine Product Offered
11.17.3 Red Light Holland Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Red Light Holland Main Business Overview
11.17.5 Red Light Holland Latest Developments
11.18 Braxia Scientific
11.18.1 Braxia Scientific Company Information
11.18.2 Braxia Scientific Psychedelic Medicine Product Offered
11.18.3 Braxia Scientific Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Braxia Scientific Main Business Overview
11.18.5 Braxia Scientific Latest Developments
11.19 Mind Cure Health
11.19.1 Mind Cure Health Company Information
11.19.2 Mind Cure Health Psychedelic Medicine Product Offered
11.19.3 Mind Cure Health Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Mind Cure Health Main Business Overview
11.19.5 Mind Cure Health Latest Developments
11.20 Entheon Biomedical
11.20.1 Entheon Biomedical Company Information
11.20.2 Entheon Biomedical Psychedelic Medicine Product Offered
11.20.3 Entheon Biomedical Psychedelic Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Entheon Biomedical Main Business Overview
11.20.5 Entheon Biomedical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Psychedelic Medicine Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Psilocybin
Table 3. Major Players of LSD
Table 4. Major Players of MDMA
Table 5. Major Players of DMT
Table 6. Major Players of Ketamine
Table 7. Major Players of Others
Table 8. Psychedelic Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Psychedelic Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Table 11. Psychedelic Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Psychedelic Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Table 14. Global Psychedelic Medicine Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Psychedelic Medicine Revenue Market Share by Player (2019-2024)
Table 16. Psychedelic Medicine Key Players Head office and Products Offered
Table 17. Psychedelic Medicine Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Psychedelic Medicine Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Psychedelic Medicine Market Size Market Share by Regions (2019-2024)
Table 22. Global Psychedelic Medicine Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Psychedelic Medicine Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Psychedelic Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Psychedelic Medicine Market Size Market Share by Country (2019-2024)
Table 26. Americas Psychedelic Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Table 28. Americas Psychedelic Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Table 30. APAC Psychedelic Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Psychedelic Medicine Market Size Market Share by Region (2019-2024)
Table 32. APAC Psychedelic Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Table 34. APAC Psychedelic Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Table 36. Europe Psychedelic Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Psychedelic Medicine Market Size Market Share by Country (2019-2024)
Table 38. Europe Psychedelic Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Table 40. Europe Psychedelic Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Psychedelic Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Psychedelic Medicine Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Psychedelic Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Psychedelic Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Psychedelic Medicine
Table 49. Key Market Challenges & Risks of Psychedelic Medicine
Table 50. Key Industry Trends of Psychedelic Medicine
Table 51. Global Psychedelic Medicine Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Psychedelic Medicine Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Psychedelic Medicine Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Psychedelic Medicine Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. COMPASS Pathways PLC Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 56. COMPASS Pathways PLC Psychedelic Medicine Product Offered
Table 57. COMPASS Pathways PLC Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. COMPASS Pathways PLC Main Business
Table 59. COMPASS Pathways PLC Latest Developments
Table 60. Pfizer Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 61. Pfizer Psychedelic Medicine Product Offered
Table 62. Pfizer Main Business
Table 63. Pfizer Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Pfizer Latest Developments
Table 65. Eli Lilly Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 66. Eli Lilly Psychedelic Medicine Product Offered
Table 67. Eli Lilly Main Business
Table 68. Eli Lilly Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Eli Lilly Latest Developments
Table 70. GlaxoSmithKline Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 71. GlaxoSmithKline Psychedelic Medicine Product Offered
Table 72. GlaxoSmithKline Main Business
Table 73. GlaxoSmithKline Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. GlaxoSmithKline Latest Developments
Table 75. Cybin Inc Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 76. Cybin Inc Psychedelic Medicine Product Offered
Table 77. Cybin Inc Main Business
Table 78. Cybin Inc Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Cybin Inc Latest Developments
Table 80. Field Trip Health Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 81. Field Trip Health Psychedelic Medicine Product Offered
Table 82. Field Trip Health Main Business
Table 83. Field Trip Health Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Field Trip Health Latest Developments
Table 85. ATAI Life Sciences Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 86. ATAI Life Sciences Psychedelic Medicine Product Offered
Table 87. ATAI Life Sciences Main Business
Table 88. ATAI Life Sciences Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. ATAI Life Sciences Latest Developments
Table 90. NUMINUS WELLNESS Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 91. NUMINUS WELLNESS Psychedelic Medicine Product Offered
Table 92. NUMINUS WELLNESS Main Business
Table 93. NUMINUS WELLNESS Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. NUMINUS WELLNESS Latest Developments
Table 95. MindMed Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 96. MindMed Psychedelic Medicine Product Offered
Table 97. MindMed Main Business
Table 98. MindMed Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. MindMed Latest Developments
Table 100. HAVN Life Sciences Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 101. HAVN Life Sciences Psychedelic Medicine Product Offered
Table 102. HAVN Life Sciences Main Business
Table 103. HAVN Life Sciences Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. HAVN Life Sciences Latest Developments
Table 105. Seelos Therapeutics Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 106. Seelos Therapeutics Psychedelic Medicine Product Offered
Table 107. Seelos Therapeutics Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Seelos Therapeutics Main Business
Table 109. Seelos Therapeutics Latest Developments
Table 110. Jannsen Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 111. Jannsen Psychedelic Medicine Product Offered
Table 112. Jannsen Main Business
Table 113. Jannsen Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Jannsen Latest Developments
Table 115. Acadia Pharmaceuticals Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 116. Acadia Pharmaceuticals Psychedelic Medicine Product Offered
Table 117. Acadia Pharmaceuticals Main Business
Table 118. Acadia Pharmaceuticals Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. Acadia Pharmaceuticals Latest Developments
Table 120. Intellipharmaceutics Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 121. Intellipharmaceutics Psychedelic Medicine Product Offered
Table 122. Intellipharmaceutics Main Business
Table 123. Intellipharmaceutics Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Intellipharmaceutics Latest Developments
Table 125. Revive Therapeutics Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 126. Revive Therapeutics Psychedelic Medicine Product Offered
Table 127. Revive Therapeutics Main Business
Table 128. Revive Therapeutics Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Revive Therapeutics Latest Developments
Table 130. Mydecine Innovations Group Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 131. Mydecine Innovations Group Psychedelic Medicine Product Offered
Table 132. Mydecine Innovations Group Main Business
Table 133. Mydecine Innovations Group Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. Mydecine Innovations Group Latest Developments
Table 135. Red Light Holland Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 136. Red Light Holland Psychedelic Medicine Product Offered
Table 137. Red Light Holland Main Business
Table 138. Red Light Holland Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Red Light Holland Latest Developments
Table 140. Braxia Scientific Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 141. Braxia Scientific Psychedelic Medicine Product Offered
Table 142. Braxia Scientific Main Business
Table 143. Braxia Scientific Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. Braxia Scientific Latest Developments
Table 145. Mind Cure Health Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 146. Mind Cure Health Psychedelic Medicine Product Offered
Table 147. Mind Cure Health Main Business
Table 148. Mind Cure Health Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 149. Mind Cure Health Latest Developments
Table 150. Entheon Biomedical Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 151. Entheon Biomedical Psychedelic Medicine Product Offered
Table 152. Entheon Biomedical Main Business
Table 153. Entheon Biomedical Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 154. Entheon Biomedical Latest Developments
Table 1. Psychedelic Medicine Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Psilocybin
Table 3. Major Players of LSD
Table 4. Major Players of MDMA
Table 5. Major Players of DMT
Table 6. Major Players of Ketamine
Table 7. Major Players of Others
Table 8. Psychedelic Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Psychedelic Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Table 11. Psychedelic Medicine Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Psychedelic Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Table 14. Global Psychedelic Medicine Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Psychedelic Medicine Revenue Market Share by Player (2019-2024)
Table 16. Psychedelic Medicine Key Players Head office and Products Offered
Table 17. Psychedelic Medicine Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Psychedelic Medicine Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Psychedelic Medicine Market Size Market Share by Regions (2019-2024)
Table 22. Global Psychedelic Medicine Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Psychedelic Medicine Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Psychedelic Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Psychedelic Medicine Market Size Market Share by Country (2019-2024)
Table 26. Americas Psychedelic Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Table 28. Americas Psychedelic Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Table 30. APAC Psychedelic Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Psychedelic Medicine Market Size Market Share by Region (2019-2024)
Table 32. APAC Psychedelic Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Table 34. APAC Psychedelic Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Table 36. Europe Psychedelic Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Psychedelic Medicine Market Size Market Share by Country (2019-2024)
Table 38. Europe Psychedelic Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Table 40. Europe Psychedelic Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Psychedelic Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Psychedelic Medicine Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Psychedelic Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Psychedelic Medicine Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Psychedelic Medicine
Table 49. Key Market Challenges & Risks of Psychedelic Medicine
Table 50. Key Industry Trends of Psychedelic Medicine
Table 51. Global Psychedelic Medicine Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Psychedelic Medicine Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Psychedelic Medicine Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Psychedelic Medicine Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. COMPASS Pathways PLC Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 56. COMPASS Pathways PLC Psychedelic Medicine Product Offered
Table 57. COMPASS Pathways PLC Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. COMPASS Pathways PLC Main Business
Table 59. COMPASS Pathways PLC Latest Developments
Table 60. Pfizer Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 61. Pfizer Psychedelic Medicine Product Offered
Table 62. Pfizer Main Business
Table 63. Pfizer Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Pfizer Latest Developments
Table 65. Eli Lilly Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 66. Eli Lilly Psychedelic Medicine Product Offered
Table 67. Eli Lilly Main Business
Table 68. Eli Lilly Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Eli Lilly Latest Developments
Table 70. GlaxoSmithKline Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 71. GlaxoSmithKline Psychedelic Medicine Product Offered
Table 72. GlaxoSmithKline Main Business
Table 73. GlaxoSmithKline Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. GlaxoSmithKline Latest Developments
Table 75. Cybin Inc Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 76. Cybin Inc Psychedelic Medicine Product Offered
Table 77. Cybin Inc Main Business
Table 78. Cybin Inc Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Cybin Inc Latest Developments
Table 80. Field Trip Health Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 81. Field Trip Health Psychedelic Medicine Product Offered
Table 82. Field Trip Health Main Business
Table 83. Field Trip Health Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Field Trip Health Latest Developments
Table 85. ATAI Life Sciences Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 86. ATAI Life Sciences Psychedelic Medicine Product Offered
Table 87. ATAI Life Sciences Main Business
Table 88. ATAI Life Sciences Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. ATAI Life Sciences Latest Developments
Table 90. NUMINUS WELLNESS Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 91. NUMINUS WELLNESS Psychedelic Medicine Product Offered
Table 92. NUMINUS WELLNESS Main Business
Table 93. NUMINUS WELLNESS Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. NUMINUS WELLNESS Latest Developments
Table 95. MindMed Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 96. MindMed Psychedelic Medicine Product Offered
Table 97. MindMed Main Business
Table 98. MindMed Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. MindMed Latest Developments
Table 100. HAVN Life Sciences Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 101. HAVN Life Sciences Psychedelic Medicine Product Offered
Table 102. HAVN Life Sciences Main Business
Table 103. HAVN Life Sciences Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. HAVN Life Sciences Latest Developments
Table 105. Seelos Therapeutics Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 106. Seelos Therapeutics Psychedelic Medicine Product Offered
Table 107. Seelos Therapeutics Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Seelos Therapeutics Main Business
Table 109. Seelos Therapeutics Latest Developments
Table 110. Jannsen Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 111. Jannsen Psychedelic Medicine Product Offered
Table 112. Jannsen Main Business
Table 113. Jannsen Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Jannsen Latest Developments
Table 115. Acadia Pharmaceuticals Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 116. Acadia Pharmaceuticals Psychedelic Medicine Product Offered
Table 117. Acadia Pharmaceuticals Main Business
Table 118. Acadia Pharmaceuticals Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. Acadia Pharmaceuticals Latest Developments
Table 120. Intellipharmaceutics Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 121. Intellipharmaceutics Psychedelic Medicine Product Offered
Table 122. Intellipharmaceutics Main Business
Table 123. Intellipharmaceutics Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Intellipharmaceutics Latest Developments
Table 125. Revive Therapeutics Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 126. Revive Therapeutics Psychedelic Medicine Product Offered
Table 127. Revive Therapeutics Main Business
Table 128. Revive Therapeutics Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Revive Therapeutics Latest Developments
Table 130. Mydecine Innovations Group Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 131. Mydecine Innovations Group Psychedelic Medicine Product Offered
Table 132. Mydecine Innovations Group Main Business
Table 133. Mydecine Innovations Group Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. Mydecine Innovations Group Latest Developments
Table 135. Red Light Holland Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 136. Red Light Holland Psychedelic Medicine Product Offered
Table 137. Red Light Holland Main Business
Table 138. Red Light Holland Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Red Light Holland Latest Developments
Table 140. Braxia Scientific Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 141. Braxia Scientific Psychedelic Medicine Product Offered
Table 142. Braxia Scientific Main Business
Table 143. Braxia Scientific Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. Braxia Scientific Latest Developments
Table 145. Mind Cure Health Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 146. Mind Cure Health Psychedelic Medicine Product Offered
Table 147. Mind Cure Health Main Business
Table 148. Mind Cure Health Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 149. Mind Cure Health Latest Developments
Table 150. Entheon Biomedical Details, Company Type, Psychedelic Medicine Area Served and Its Competitors
Table 151. Entheon Biomedical Psychedelic Medicine Product Offered
Table 152. Entheon Biomedical Main Business
Table 153. Entheon Biomedical Psychedelic Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 154. Entheon Biomedical Latest Developments
LIST OF FIGURES
Figure 1. Psychedelic Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psychedelic Medicine Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Psychedelic Medicine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Psychedelic Medicine Sales Market Share by Country/Region (2023)
Figure 8. Psychedelic Medicine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Psychedelic Medicine Market Size Market Share by Type in 2023
Figure 10. Psychedelic Medicine in Depressive Disorders
Figure 11. Global Psychedelic Medicine Market: Depressive Disorders (2019-2024) & ($ Millions)
Figure 12. Psychedelic Medicine in Post-Traumatic Stress Disorders
Figure 13. Global Psychedelic Medicine Market: Post-Traumatic Stress Disorders (2019-2024) & ($ Millions)
Figure 14. Psychedelic Medicine in Substance Abuse Disorders
Figure 15. Global Psychedelic Medicine Market: Substance Abuse Disorders (2019-2024) & ($ Millions)
Figure 16. Psychedelic Medicine in Obsessive Compulsive Disorders
Figure 17. Global Psychedelic Medicine Market: Obsessive Compulsive Disorders (2019-2024) & ($ Millions)
Figure 18. Psychedelic Medicine in Others
Figure 19. Global Psychedelic Medicine Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Psychedelic Medicine Market Size Market Share by Application in 2023
Figure 21. Global Psychedelic Medicine Revenue Market Share by Player in 2023
Figure 22. Global Psychedelic Medicine Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Psychedelic Medicine Market Size 2019-2024 ($ Millions)
Figure 24. APAC Psychedelic Medicine Market Size 2019-2024 ($ Millions)
Figure 25. Europe Psychedelic Medicine Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Psychedelic Medicine Market Size 2019-2024 ($ Millions)
Figure 27. Americas Psychedelic Medicine Value Market Share by Country in 2023
Figure 28. United States Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Psychedelic Medicine Market Size Market Share by Region in 2023
Figure 33. APAC Psychedelic Medicine Market Size Market Share by Type in 2023
Figure 34. APAC Psychedelic Medicine Market Size Market Share by Application in 2023
Figure 35. China Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Psychedelic Medicine Market Size Market Share by Country in 2023
Figure 42. Europe Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Figure 43. Europe Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Figure 44. Germany Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Psychedelic Medicine Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 58. APAC Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 59. Europe Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 61. United States Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 62. Canada Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 65. China Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 66. Japan Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 67. Korea Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 69. India Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 70. Australia Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 71. Germany Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 72. France Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 73. UK Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 74. Italy Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 75. Russia Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 76. Spain Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 79. Israel Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 82. Global Psychedelic Medicine Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Psychedelic Medicine Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Psychedelic Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psychedelic Medicine Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Psychedelic Medicine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Psychedelic Medicine Sales Market Share by Country/Region (2023)
Figure 8. Psychedelic Medicine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Psychedelic Medicine Market Size Market Share by Type in 2023
Figure 10. Psychedelic Medicine in Depressive Disorders
Figure 11. Global Psychedelic Medicine Market: Depressive Disorders (2019-2024) & ($ Millions)
Figure 12. Psychedelic Medicine in Post-Traumatic Stress Disorders
Figure 13. Global Psychedelic Medicine Market: Post-Traumatic Stress Disorders (2019-2024) & ($ Millions)
Figure 14. Psychedelic Medicine in Substance Abuse Disorders
Figure 15. Global Psychedelic Medicine Market: Substance Abuse Disorders (2019-2024) & ($ Millions)
Figure 16. Psychedelic Medicine in Obsessive Compulsive Disorders
Figure 17. Global Psychedelic Medicine Market: Obsessive Compulsive Disorders (2019-2024) & ($ Millions)
Figure 18. Psychedelic Medicine in Others
Figure 19. Global Psychedelic Medicine Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Psychedelic Medicine Market Size Market Share by Application in 2023
Figure 21. Global Psychedelic Medicine Revenue Market Share by Player in 2023
Figure 22. Global Psychedelic Medicine Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Psychedelic Medicine Market Size 2019-2024 ($ Millions)
Figure 24. APAC Psychedelic Medicine Market Size 2019-2024 ($ Millions)
Figure 25. Europe Psychedelic Medicine Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Psychedelic Medicine Market Size 2019-2024 ($ Millions)
Figure 27. Americas Psychedelic Medicine Value Market Share by Country in 2023
Figure 28. United States Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Psychedelic Medicine Market Size Market Share by Region in 2023
Figure 33. APAC Psychedelic Medicine Market Size Market Share by Type in 2023
Figure 34. APAC Psychedelic Medicine Market Size Market Share by Application in 2023
Figure 35. China Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Psychedelic Medicine Market Size Market Share by Country in 2023
Figure 42. Europe Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Figure 43. Europe Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Figure 44. Germany Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Psychedelic Medicine Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Psychedelic Medicine Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Psychedelic Medicine Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Psychedelic Medicine Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 58. APAC Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 59. Europe Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 61. United States Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 62. Canada Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 65. China Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 66. Japan Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 67. Korea Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 69. India Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 70. Australia Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 71. Germany Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 72. France Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 73. UK Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 74. Italy Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 75. Russia Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 76. Spain Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 79. Israel Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Psychedelic Medicine Market Size 2025-2030 ($ Millions)
Figure 82. Global Psychedelic Medicine Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Psychedelic Medicine Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Rigid Ureteroscopes Market Growth 2024-2030
US$ 3,660.00
February 2024
109 pages
Global Radial Artery Compression Device Market Growth 2023-2029
US$ 3,660.00
February 2023
97 pages
Global Brain PET-MRI Imaging Systems Market Growth 2023-2029
US$ 3,660.00
March 2023
95 pages
Global Osteoarthritis Medications Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
158 pages
Global Carbohydrate Antigen 242 Determination Kit Market Growth 2024-2030
US$ 3,660.00
September 2024
95 pages
